GPR40 Agonist 2

• UNSPSC Description:

  GPR40 Agonist 2 is a GPR40 agonist that can be used in the research of diabetes, extracted from patent WO2009054479A1.

• Target Antigen:

  Free Fatty Acid Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein

• Applications:

  Metabolism-sugar/lipid metabolism

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/Benzenepropanoic_acid,__beta_-1-propyn-1-yl-4-_spiro[5.5]undec-2-en-2-ylmethoxy_-,___beta_S_-.html

• Solubility:

  10 mM in DMSO

• Smiles:

  OC(C[C@H](C#CC)C(C=C1)=CC=C1OCC2=CCCC3(CCCCC3)C2)=O

• Molecular Weight:

  366.49

• References & Citations:

  [1]SHIMADA, Takashi. SPIRO-RING COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES. WO 2009054479 A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1147729-48-3